Details for New Drug Application (NDA): 202732
✉ Email this page to a colleague
NDA 202732 describes HEPARIN SODIUM PRESERVATIVE FREE, which is a drug marketed by Dr Reddys, Emerge Bioscience, Fresenius Kabi Usa, Hospira, Pfizer, Pharma Serve Ny, Sagent Pharms, and Shenzhen Techdow, and is included in nine NDAs. It is available from eleven suppliers. Additional details are available on the HEPARIN SODIUM PRESERVATIVE FREE profile page.
The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 202732
| Tradename: | HEPARIN SODIUM PRESERVATIVE FREE |
| Applicant: | Shenzhen Techdow |
| Ingredient: | heparin sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202732
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HEPARIN SODIUM PRESERVATIVE FREE | heparin sodium | INJECTABLE;INJECTION | 202732 | ANDA | Sandoz Inc. | 0781-3555 | 0781-3555-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0781-3555-25) / 2 mL in 1 VIAL, SINGLE-DOSE (0781-3555-10) |
| HEPARIN SODIUM PRESERVATIVE FREE | heparin sodium | INJECTABLE;INJECTION | 202732 | ANDA | Hepalink USA Inc. | 81952-115 | 81952-115-07 | 25 VIAL, SINGLE-DOSE in 1 CARTON (81952-115-07) / 2 mL in 1 VIAL, SINGLE-DOSE (81952-115-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1,000 UNITS/ML | ||||
| Approval Date: | Jun 12, 2014 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
